Article
A Deep Learning Framework Identifies Pathogenic Noncoding Somatic Mutations from Personal Prostate Cancer Genomes.
Cancer research - 1 Nov 2020
Wang Cheng, Li Jingjing
Abstract excerpt
Our understanding of noncoding mutations in cancer genomes has been derived primarily from mutational recurrence analysis by aggregating clinical samples on a large scale. These cohort-based approaches cannot directly identify individual pathogenic noncoding mutations from personal cancer genomes. Therefore, although most somatic mutations are localized in the noncoding cancer genome, their effects on driving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
